PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders



Status:Completed
Conditions:HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:13 - 24
Updated:3/1/2017
Start Date:March 2015
End Date:February 2016

Use our guide to learn which trials are right for you!

This is an observational study involving retrospective and prospective medical record review
covering a total maximum of 104 weeks (24 months) per subject. An Audio Computer- Assisted
Self-Interview (ACASI) at study entry will assess demographic and psychosocial variables of
study subjects. Data will also be collected to assess clinic level variables. Definitions of
engagement, prescription of antiretroviral therapy (ART), and viral suppression in the
Continuum of Care (CoC) will utilize common definitions including those by U.S. Department
of Health and Human Services (DHHS) and Health Resources and Services Administration (HRSA)
HIV/AIDS Bureau (HAB). Data will be collected in a large, simple trial design manner to
provide all elements for both the primary and secondary outcomes.

This is an observational study involving retrospective and prospective medical record review
covering a total maximum of 104 weeks (24 months) per subject. Behavioral data will be
collected via ACASI at study entry to assess demographic and psychosocial variables of study
subjects. All other data (biomedical, ART, healthcare utilization) at subsequent study
visits will be collected via medical record abstraction. Information about missed visits as
well as other healthcare utilization data can be abstracted from electronic appointment
systems or other electronic systems at the clinical sites. Subject data will be abstracted
from medical records for up to a maximum 26 weeks prior to the baseline study visit, as well
as up to a maximum 78 weeks after the baseline study visit or through January 31, 2017,
whichever occurs first, for a total maximum of 104 weeks or two years per subject. Data will
also be collected from each Adolescent Medicine Trials Unit to assess clinic level variables
at baseline (within 30 days of protocol registration) and 48 and 96 weeks after baseline.
Definitions of engagement, prescription of antiretroviral therapy (ART), and viral
suppression in the Continuum of Care (CoC) will utilize common definitions including those
by U.S. Department of Health and Human Services (DHHS) and Health Resources and Services
Administration (HRSA) HIV/AIDS Bureau (HAB). Data will be collected in a large, simple trial
design manner to provide all elements for both the primary and secondary outcomes.

Inclusion Criteria:

- Laboratory evidence of HIV-1 infection per Centers for Disease Control and Prevention
(CDC) Surveillance Case Definition for HIV Infection, 2014 (Section 1.1)
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm;

- Behaviorally-acquired HIV after age 9 years;

- Age 13 through 24 years, inclusive, at the baseline visit (Enrollment);

- Planning to receive HIV medical care at an AMTU or at any clinical site that is part
of the AMTU for the duration of study follow-up

• If transition to an adult health care provider must occur during the course of
study participation, continued AMTU staff accessibility to medical and appointment
records;

- Ability for the AMTU staff to access medical and appointment records for a maximum of
78 weeks after enrollment or through February 2017, whichever occurs first;

- Ability to understand spoken English;

- Willing and able to provide signed informed consent or assent;

NOTE: If consent/assent is obtained > 4 weeks prior to the enrollment date, reaffirmation
of consent must be obtained prior to starting the Baseline visit.

-Parent or Legal Guardian permission, if applicable; and

In addition to all the criteria listed above, to be considered eligible for enrollment
after August 31, 2015, an individual must also meet the following criterion.

-Must be considered either: (a) newly engaged in HIV medical care defined as no previous
initial comprehensive HIV medical care visit with consent occurring before, at the time
of, or within four weeks following that initial comprehensive visit; or (b) newly
re-engaged in HIV medical care defined as attending the last medical appointment more than
52 weeks ago.

*NOTE: The initial HIV medical care appointment is defined as a routine HIV medical
appointment where the adolescent attends with a medical provider authorized to prescribe
medication.

This HIV medical appointment must be a non-emergency, routine condition-focused exam AND
one or more of the following:

- CD4, VL lab draw and/or review of these lab results;

- Discussion around HIV ART options;

- Primary and/or secondary HIV prevention education and counseling; or

- Diagnosis and treatment of complications of HIV, and of AIDS-defining conditions.

Exclusion Criteria:

- Presence of serious psychiatric symptoms (e.g., active hallucinations, thought
disorder) that would impair the individual's ability to provide true informed consent
or participate in the baseline ACASI*;

- Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior) at the
time of consent or the baseline ACASI*; or

- Intoxicated or under the influence of alcohol or other substances at the time of
consent or the baseline ACASI*

- NOTE: If consent/assent is obtained prior to the enrollment date, assessment for
these exclusion criteria must be performed again prior to administration of the
baseline ACASI (Enrollment). If any are present, the subject cannot be enrolled;
do not administer the ACASI. Reassessment of eligibility and enrollment may take
place at a later date per the discretion of the treating clinician.
We found this trial at
14
sites
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
?
mi
from
Bronx, NY
Click here to add this to my saved trials
3400 N Charles St
Baltimore, Maryland 21205
410-516-8000
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
262 Danny Thomas Pl
Memphis, Tennessee 38105
(901) 495-3300
St. Jude Children's Research Hospital St. Jude is unlike any other pediatric treatment and research...
?
mi
from
Memphis, TN
Click here to add this to my saved trials
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4202 E Fowler Ave
Tampa, Florida 33620
(813) 974-2011
University of South Florida The University of South Florida is a high-impact, global research university...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
Aurora, CA
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
3901 Beaubien St
Detroit, Michigan 48201
(313) 745-5437
Children's Hospital of Michigan Since 1886, the Children's Hospital of Michigan has been dedicated to...
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
Los Angeles, California 90027
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
1430 Tulane Ave Suite SL32
New Orleans, Louisiana 70112
(504) 588-5912
Tulane University Health Sciences Center One of the nation's most recognized centers for medical education,...
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
Washington, District of Columbia 20010
?
mi
from
Washington,
Click here to add this to my saved trials